Record recurring EBIT, up +12.7% in local currency, up +8.1% in CHF Net sales up +1.6% in local currency. Record recurring EBIT margin of 23.2% (+210 bps) in Q2 2024 +10.0% growth in EPS before impairment and divestments Disciplined M&A execution continues with 11 value-accretive acquisitions and 4 divestments FY 2024 updated guidance: recurring EBIT...